USANA Health Sciences, Inc. (NYSE:USNA) Q2 2022 Earnings Conference Call July 27, 2022 11:00 AM ET
Company Participants
Andrew Masuda - Director, IR
Kevin Guest - CEO & Chairman
Jim Brown - President
Doug Hekking - CFO
Brent Neidig - Chief Officer & MD, China
Walter Noot - COO
Conference Call Participants
Chris Neamonitis - Jefferies
Doug Lane - Lane Research
Linda Bolton Weiser - D.A. Davidson
Operator
Good day and welcome to USANA Health Sciences' Second Quarter Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Andrew Masuda, Director of Investor Relations. Please go ahead, sir.
Andrew Masuda
Thank you and good morning, everyone. We appreciate you joining us to review our second quarter results.
Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website.
As a reminder, during the course of this conference call, management will be making forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ perhaps materially from the results projected in such forward-looking statements.
Examples of these statements include those regarding our strategies and outlook for fiscal year 2022, as well as uncertainty related to the magnitude, scope, and duration of the impact of the COVID-19 pandemic to our business, operations, and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific Risk Factors and financial data contained in our most recent filings with the SEC.
I'm joined by our CEO and Chairman of the Board, Kevin Guest; our President, Jim Brown; our Chief Financial Officer, Doug Hekking; as well as other executives.
Yesterday, after the market closed, we announced our second quarter results and posted our management commentary document on the company's website.
We'll now hear brief remarks from Kevin before opening the call for questions.
Kevin Guest
Thank you, Andrew, and good morning, everyone. We appreciate you joining us to review our second quarter results.
[Technical Difficulty] prerelease and our final earnings release for the second quarter yesterday, our operating performance during the second quarter was negatively impacted by COVID-related lockdowns, restrictions and other disruptions in several key markets. These disruptions also added negative effect on the regional sales program we offered during the quarter. Despite the short-term disruptions to our business, we remain confident in our business strategy and our prospects for future customer and sales growth. Although, we continue to prioritize the alignment of spending with sales performance in the near-term, the health of our balance sheet and our generation of free cash flow will allow us to continue making the necessary investments to position USANA for future growth.